Devicare Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 16

Devicare General Information

Description

Operator of a specialty biotech company intended to develop medical treatments in Urology. The company combines the most recent scientific advances in nutritional therapy with digital technologies, enabling doctors and patients to maintain good urinary health, improve quality of life, and avoid complications related to an unbalanced diet.

Contact Information

Website
www.devicare.com
Formerly Known As
Global Health Home Devices
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sant Cugat Green Building
  • Avenue generalitat, 163-167
  • 08174 Barcelona
  • Spain
+34 664
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Digital Health, Life Sciences
Corporate Office
  • Sant Cugat Green Building
  • Avenue generalitat, 163-167
  • 08174 Barcelona
  • Spain
+34 664

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Devicare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private Completed Generating Revenue
10. Later Stage VC (Series A) 06-Jan-2021 Completed Generating Revenue
9. Later Stage VC 06-Apr-2019 Completed Generating Revenue
8. Debt - General 22-Dec-2017 Completed Generating Revenue
7. Debt - General 06-Sep-2017 Completed Generating Revenue
6. Seed Round 05-May-2017 Completed Generating Revenue
5. Angel (individual) 01-Sep-2016 Completed Startup
4. Seed Round 26-Jun-2014 Completed Startup
3. Product Crowdfunding 17-Mar-2014 $5.58K $927K Completed Startup
2. Seed Round 19-Nov-2013 $13.6K $927K Completed Startup
To view Devicare’s complete valuation and funding history, request access »

Devicare Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 37,800 $0.012171 $8.05 $8.05 1x $8.05 4.28%
Ordinary 33,400 $0.012171 $25.51 $25.51 1x $25.51 3.78%
To view Devicare’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Devicare Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Devicare Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4084836-A1 Compositions for clinical complications associated to devices implanted in the urinary tract Active 30-Dec-2019
EP-4084836-B1 Compositions for clinical complications associated to devices implanted in the urinary tract Active 30-Dec-2019
ES-3001441-T3 Compositions for clinical complications associated to devices implanted in the urinary tract Active 30-Dec-2019
US-20230093480-A1 Compositions for clinical complications associated to devices implanted in the urinary tract Pending 30-Dec-2019
JP-2023508181-A Compositions for clinical complications associated with devices implanted in the urinary tract Pending 30-Dec-2019 A61K31/6615
To view Devicare’s complete patent history, request access »

Devicare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Devicare Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced MedTech Holdings PE-Backed Company Minority
Medex Partners Venture Capital Minority
Ship2B Accelerator/Incubator Minority
Abac Nest Ventures Venture Capital Minority
EMESA Corporación Empresarial Asset Manager Minority
You’re viewing 5 of 16 investors. Get the full list »

Devicare Investments (1)

Devicare’s most recent deal was a Corporate Asset Purchase with M4 Pharma (Repairing Antiseptic Gel). The deal was made on 02-Feb-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
M4 Pharma (Repairing Antiseptic Gel) 02-Feb-2021 Corporate Asset Purchase Buildings and Property
To view Devicare’s complete investments history, request access »

Ready to get started?

Request a free trial

Devicare FAQs

  • When was Devicare founded?

    Devicare was founded in 2011.

  • Where is Devicare headquartered?

    Devicare is headquartered in Barcelona, Spain.

  • What is the size of Devicare?

    Devicare has 32 total employees.

  • What industry is Devicare in?

    Devicare’s primary industry is Pharmaceuticals.

  • Is Devicare a private or public company?

    Devicare is a Private company.

  • What is Devicare’s current revenue?

    The current revenue for Devicare is .

  • How much funding has Devicare raised over time?

    Devicare has raised $12.8M.

  • Who are Devicare’s investors?

    Advanced MedTech Holdings, Medex Partners, Ship2B, Abac Nest Ventures, and EMESA Corporación Empresarial are 5 of 16 investors who have invested in Devicare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »